EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A brief report: absence of elevated circulating NETosis markers in long-term long COVID

Bart Humer, Hande Eyisoylu, Julia C Berentschot, L Martine Bek, Chantal A Boly, Merel E Hellemons, Moniek P M de Maat

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1920533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Bart Humer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Extracellular Traps, COVID-19, Biomarkers. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neutrophil extracellular trap (NET) formation (NETosis) has been proposed as a contributor to the pathophysiology of Long COVID (LC). However, it remains unclear whether markers of systemic NETosis remain elevated in individuals with persistent symptoms years after the initial infection.

Methods

To assess NETosis, we quantified MPO-DNA, Histone DNA, and Citrullinated H3 levels in the plasma of 51 patients with prolonged LC (mean disease duration of three years), and compared them with 52 age- and sex-matched healthy controls.

Results

No significant differences were observed between participants with LC and healthy controls for any of the three NETosis markers. Hierarchical clustering reveals no specific subgroups in the patient group. Furthermore, NETosis marker levels were not associated with overall symptom burden or individual symptom domains.

Conclusions

In this cohort of individuals with long-term LC, we found no evidence of persistent systemic NETosis. These findings suggest that elevated circulating NETosis markers are not a universal feature of long-term LC and may indicate that neutrophil activation observed during acute or early post-acute disease does not persist in long-term disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsCOVID-19BiomarkersHumansFemaleMaleMiddle AgedSARS-CoV-2HistonesPost-Acute COVID-19 SyndromeNeutrophilsAdultPeroxidaseNeutrophil ActivationAgedCase-Control StudiesDNA

Stichwörter der Autor:innen

Long COVIDNETosisbiomarkersinflammationneutrophilspost-COVIDpost-acute sequalae of SARS-CoV-2 infection

Substanzen

BiomarkersHistonesPeroxidaseDNA

Autor:innen und Institutionen

  • Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Department of Hematology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
  • Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands.
  • Department of Intensive Care, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.

Zitieren

APA

Humer, B., Eyisoylu, H., Berentschot, J. C., Bek, L. M., Boly, C. A., Hellemons, M. E., & de Maat, M. P. M. (2026). A brief report: absence of elevated circulating NETosis markers in long-term long COVID. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1920533

Vancouver

Humer B, Eyisoylu H, Berentschot JC, Bek LM, Boly CA, Hellemons ME, et al. A brief report: absence of elevated circulating NETosis markers in long-term long COVID. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1920533

BibTeX
@article{Humer2026,
  author = {Humer, Bart and Eyisoylu, Hande and Berentschot, Julia C and Bek, L Martine and Boly, Chantal A and Hellemons, Merel E and de Maat, Moniek P M},
  title = {A brief report: absence of elevated circulating NETosis markers in long-term long COVID},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1920533}
}
Kostenlos starten →